Skip to main content

Table 6 Multivariate analysis for progression free survival (PFS) in Subgroup A and Subgroup B

From: Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)

PFS

 

Parameter

SE

HR

95%CI

WAld’s p

Subgroup A(1st line, chemo-naïve)

Age

−0.028

0.011

0.973

0.952-0.994

0.012

TYMS

     

 aberrant vs. normal

0.577

0.253

1.780

1.084-2.923

0.563

Treatment

     

 platinum vs. taxanes

0.235

0.407

1.265

0.570-2.811

0.563

 tax/plat vs. taxanes

−0.220

0.303

0.802

0.443-1.452

0.467

 other vs. taxanes

0.088

0.376

1.092

0.522-2.282

0.816

aberrant TYMS *platinum

−1,687

0.564

  

0.003

aberrant TYMS *tax/plat

−1.200

0.433

  

0.006

Subgroup B(1st line, chemo-naïve)

Age

−0.002

0.010

0.978

0.959-0.998

0.034

TYMS

     

 aberrant vs. normal

0.539

0.255

1.714

1.040-2.824

0.034

Treatment

     

 platinum vs. taxanes

0.293

0.382

1.340

0.0633-2.836

0.444

 tax/plat vs. taxanes

−0.129

0.285

0.879

0.502-1.537

0.650

 other vs. taxanes

−6.631

0.439

0.532

0.225-1.258

0.151

aberrant TYMS*platinum

−1.719

0.551

  

0.002

aberrant TYMS*tax/plat

−1.233

0.420

  

0.003

aberrant TYMS *other  treatment

−1.375

0.642

  

0.032